CANNABIS IS BECOMING A GLOBAL MEDICAL INDUSTRY
Markets. Medicine. Standards.
Market intelligence, regulation, and industry news across Australia, New Zealand, Thailand, the United Kingdom and Germany.
Covering the evolution of regulated medical cannabis markets — from prescribing and policy to operators and supply chains.
About Leaflit
A Cannabis Industry Magazine Focused on Real Markets
Leaflit is a digital publication covering the business, regulation, and development of medical cannabis markets. While much of the global conversation still centers on recreational use, the most consequential growth is taking place in structured, regulated environments.
We focus on the markets where that shift is happening in real time — Australia, New Zealand, Thailand, the United Kingdom and Germany — alongside key developments across Europe and North America. Leaflit sits at the intersection of healthcare, policy, and commercial cannabis, offering clear insight into how the industry is actually evolving.
Coverage Includes
- Cannabis industry news and market developments
- Regulatory frameworks and policy changes
- Prescribing trends and patient access
- Listed cannabis companies and capital markets
- Supply chain, imports, and distribution dynamics
Market Focus
Focused on Emerging and Regulated Medical Cannabis Markets
These jurisdictions matter because they are where policy, prescribing, and market structure are converging most visibly.
🇦🇺 Australia
Mature TGA framework, expanding prescriber base, and a leading global benchmark for regulated medical access.
🇳🇿 New Zealand
Regulated access pathways are taking shape, with growing interest in domestic production and supply.
🇹🇭 Thailand
Asia's most progressive jurisdiction, now navigating significant regulatory reform with regional implications.
🇬🇧 United Kingdom
Specialist-led prescribing continues to grow, alongside closer NHS and private sector scrutiny.
🇩🇪 Germany
Europe's largest market, with adult-use legalisation developing alongside a robust medical framework.
What Sets Leaflit Apart
In a media landscape cluttered with speculation and promotional content, Leaflit delivers grounded intelligence built for industry professionals.
Journalistic Standards
Coverage is factual, sourced, and written to trade publication standards. No commercial bias, no promotional spin.
Regulatory Depth
We go beyond headlines to examine policy frameworks, prescribing data, and legislative shifts. The focus is on what changes for operators, investors, and clinicians.
Capital Markets Coverage
We track listed companies, capital raises, M&A, and investor sentiment across ASX, LSE, and global exchanges. Every move is placed in commercial context.
Intelligence
The Regulated Cannabis Sector Is Growing Fast
Medical cannabis is moving from an emerging category to a structured industry, drawing institutional capital, multinational operators, and sustained regulatory scrutiny. The markets Leaflit covers operate under different regulatory models, serve distinct patient populations, and sit at varying stages of maturity.
Analysis of this sector requires more than headline coverage. It means tracking how policy shifts affect prescribing volumes, how supply chains shape product availability, and how listed companies respond to changing compliance demands.
Leaflit provides the intelligence layer that professionals, investors, and regulators need to navigate a fast-moving global sector.
5
Core Markets
Australia, New Zealand, Thailand, UK, Germany
12
Months Free
Full digital magazine access with every subscription
3+
Regions Reported
Europe, Canada, and the United States beyond core markets
Coverage Pillars
From Policy to Supply Chain — The Full Industry Picture
Leaflit's editorial framework spans the full value chain of regulated medical cannabis, from policy through patient access to commercial outcomes.
Policy & Regulation
Legislative changes, scheduling decisions, and regulatory reform across the five core markets. Policy shifts are translated into clear commercial implications.
Prescribing & Patient Access
Prescriber approvals, patient numbers, and access pathways. Clinical adoption rates and barriers remain central to market trajectories.
Supply Chain & Distribution
Import regulations, cultivation licences, distribution agreements, and product availability. The operational infrastructure underpinning each market.
Listed Companies & Investment
ASX, LSE, and globally listed cannabis companies. Coverage includes capital raises, earnings, strategic moves, and investor sentiment.
Industry Events
FROM CUP WINNER TO GLOBAL STRAIN
How underground genetics become market leaders
CONFERENCES & CUPS
Where trends are born before they scale
Cannabis cups and industry conferences are no longer fringe events. They are the earliest signal layer for genetics, operators, and investors tracking what moves from underground to mainstream.
- Strain performance and genetics recognition
- Operator and brand visibility
- Investor and media attendance trends
- Regulatory and policy side sessions
- Cross-market networking and deal flow
Why It Matters for Markets
A cup-winning cultivar in one jurisdiction often signals the next import approval in another. Leaflit tracks the event circuit as an early indicator of commercial and regulatory momentum.
Cups
Strain validation before commercial scale
Conferences
Policy, capital, and operator intelligence in one room
Leaflit
Connecting event signals to market outcomes
Who Reads Leaflit
Leaflit is written for professionals operating at the intersection of healthcare, policy, and commerce in the regulated cannabis sector.
Industry Operators
Cultivators, importers, distributors, pharmacies, and clinic operators tracking regulatory changes, market developments, and competitive intelligence.
Investors & Analysts
Fund managers, private equity, and retail investors monitoring listed cannabis companies, capital activity, and commercial fundamentals.
Regulators & Policy Professionals
Government bodies, health agencies, and policy advisors tracking how international frameworks operate across comparable jurisdictions.
Healthcare Stakeholders
Clinicians, pharmacists, and medical associations following prescribing trends, clinical access developments, and cannabis in patient care.
Subscribe
A Cannabis Industry Magazine Focused on Real Markets
12 months free access to the Leaflit digital magazine.
Leaflit covers the markets, operators, regulations, and capital shaping the global regulated medical cannabis industry.
No noise. No promotional content. Just industry insight.
What You Receive
- Full access to the Leaflit digital magazine
- 12 months free — no credit card required
- Ongoing cannabis industry updates
- Market intelligence across 5 core jurisdictions
- Regulatory and policy analysis
- Listed company and capital market coverage
We respect your inbox. Unsubscribe at any time.
Subscribe
GET FULL ACCESS TO LEAFLIT
Markets. Medicine. Standards.
12 months free access. No payment required. No credit card.
Email address *
your@email.comFirst name
First name (optional)We respect your inbox. Unsubscribe at any time. Your details will never be shared.
Focused on Emerging and Regulated Medical Cannabis Markets
Leaflit Media is a global cannabis industry publication covering medical cannabis markets, regulation, and business developments. We report on the high-growth, regulated jurisdictions where the industry is maturing — Australia, New Zealand, Thailand, the United Kingdom, and Germany — with additional coverage from Europe, Canada, and the United States.
Read the Magazine
Access Issue #1 and all future editions of the Leaflit digital magazine.
Subscribe Free
12 months complimentary access. No credit card. Unsubscribe at any time.
Contact
Editorial, partnership, and media enquiries welcome.
© 2026 Leaflit Media. All rights reserved.